MrC's Smallcap Sweeps for June 2021
Posted: June 1st, 2021, 7:50 am
Smallcap Sweep. 01-Jun-21
M&C Saatchi (SAA) guides FY ahead of consensus expectations after strong first 4 months. Also increased 3 year bank financing. [SP=128 Cap=156m]
Ten Lifestyle (TENG) client contract increased to Medium contract, with the potential to develop into Large. Also launch of new concierge programmes with a Scandinavian bank and a Fintech card product under an existing Medium contract. No material impact on H2 though. [SP=109 Cap=89m]
Avacta (AVCT) confirms rumour of error (by partner Mologic) in CE mark submission for professional use of rapid covid test. Does not expect that the error will cause a delay to first commercial sales. However the test referenced in a social media post was an unrelated Mologic covid test. [SP=236 Cap=598m]
Sareum (SAR) £900k subscription at 2.8p, a 8% premium, to progress SDC-1801 TYK2/JAK1 inhibitor drug development and to keep the lights on. [SP=2.56 Cap=85m]
Zaim Credit Systems (ZAIM) hails strong Q1 with loans issued up 34% on Q4. In line? "Focus of the Group is now to maximise growth and customer numbers over profitability and gain as much market share as possible over the near term." [SP=4.35 Cap=19m]
Sensyne Health (SENS) UK Gov't contract to use MagnifEye AI technology for reading COVID rapid tests. "Phased national roll-out over a three-month period in care homes, GP practices and selected private sector organisations with large workforces." [SP=151 Cap=249m]
Immotion (IMMO) all Covid related capacity restrictions lifted in Las Vegas, home to co's largest location-based installation. Also continues to see revenues recover strongly at Location-based Entertainment sites. [SP=5.65 Cap=23m]
Hyve (HYVE) confirms rumour of placing/funding talks. "Board will prioritise minimal dilution to existing shareholders as well as the optionality to move quickly as earnings accretive acquisition opportunities arise." [SP=131.4 Cap=348m]
Scholium (SCHO) guides H2(Mar) loss marginally lower than H1. Expects H1 loss too. [SP=30 Cap=5m]
National World (NWOR) after a superior torrent of MBA BS ('Delayering and flattening management structures'..commercially homogeneous markets ...leveraging existing Group resources') it finally says trading is in line. [SP=22 Cap=57m]
Avingtrans (AVG) second phase of the contract to provide high integrity stainless steel storage boxes for Sellafield, 'underpins' outlook for FY22 and beyond. [SP=330 Cap=106m]
Coral Products (CRU) guides FY(Apr) rev-cont at least £10.7m, up 23%, pretax £3m (-£0.8m). Current year in line. [SP=13.85 Cap=12m]
In line: OTAQ, CHH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk/index.aspx?limit=-1
@MrContrarian
M&C Saatchi (SAA) guides FY ahead of consensus expectations after strong first 4 months. Also increased 3 year bank financing. [SP=128 Cap=156m]
Ten Lifestyle (TENG) client contract increased to Medium contract, with the potential to develop into Large. Also launch of new concierge programmes with a Scandinavian bank and a Fintech card product under an existing Medium contract. No material impact on H2 though. [SP=109 Cap=89m]
Avacta (AVCT) confirms rumour of error (by partner Mologic) in CE mark submission for professional use of rapid covid test. Does not expect that the error will cause a delay to first commercial sales. However the test referenced in a social media post was an unrelated Mologic covid test. [SP=236 Cap=598m]
Sareum (SAR) £900k subscription at 2.8p, a 8% premium, to progress SDC-1801 TYK2/JAK1 inhibitor drug development and to keep the lights on. [SP=2.56 Cap=85m]
Zaim Credit Systems (ZAIM) hails strong Q1 with loans issued up 34% on Q4. In line? "Focus of the Group is now to maximise growth and customer numbers over profitability and gain as much market share as possible over the near term." [SP=4.35 Cap=19m]
Sensyne Health (SENS) UK Gov't contract to use MagnifEye AI technology for reading COVID rapid tests. "Phased national roll-out over a three-month period in care homes, GP practices and selected private sector organisations with large workforces." [SP=151 Cap=249m]
Immotion (IMMO) all Covid related capacity restrictions lifted in Las Vegas, home to co's largest location-based installation. Also continues to see revenues recover strongly at Location-based Entertainment sites. [SP=5.65 Cap=23m]
Hyve (HYVE) confirms rumour of placing/funding talks. "Board will prioritise minimal dilution to existing shareholders as well as the optionality to move quickly as earnings accretive acquisition opportunities arise." [SP=131.4 Cap=348m]
Scholium (SCHO) guides H2(Mar) loss marginally lower than H1. Expects H1 loss too. [SP=30 Cap=5m]
National World (NWOR) after a superior torrent of MBA BS ('Delayering and flattening management structures'..commercially homogeneous markets ...leveraging existing Group resources') it finally says trading is in line. [SP=22 Cap=57m]
Avingtrans (AVG) second phase of the contract to provide high integrity stainless steel storage boxes for Sellafield, 'underpins' outlook for FY22 and beyond. [SP=330 Cap=106m]
Coral Products (CRU) guides FY(Apr) rev-cont at least £10.7m, up 23%, pretax £3m (-£0.8m). Current year in line. [SP=13.85 Cap=12m]
In line: OTAQ, CHH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk/index.aspx?limit=-1
@MrContrarian